Davis Capital Management
AMPH icon

Davis Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Davis Capital Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$52 Hold
2
– – ﹤0.01% 1127
2026
Q2 		$40 Buy
+2
New +$40 ﹤0.01% 1242

Other funds holding AMPH

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $33.9B AUM 47.7% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Davis Capital Management's AMPH Position: Q3 2026 in Review

Davis Capital Management held its Amphastar Pharmaceuticals (AMPH) position steady in Q3 2026 at 2 shares worth $52. The position accounts for ﹤0.01% of the portfolio, ranked #1127.

Davis Capital Management first reported a position in AMPH in Q2 2026 and has held it in 2 quarters since. 175 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.

  • Davis Capital Management held 2 shares of Amphastar Pharmaceuticals worth $52 as of Q3 2026.
  • Davis Capital Management left its Amphastar Pharmaceuticals share count unchanged in Q3 2026.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Davis Capital Management's portfolio in Q3 2026, its #1127 holding.
  • Davis Capital Management first reported a position in Amphastar Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 175 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.